STATE STREET CORP

Holdings History for Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (AVDL)

Symbol: AVDL on Nasdaq
Investment type: Equity / American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Jun 2024		-0%	$0	0	-36,844	-100%	$18.78	Q2 2024
31 Mar 2024	0%	-0%	$622,295	36,844	-5,262	-12%	$16.89	Q1 2024
31 Dec 2023	0%	+0%	$594,537	42,106	+11,800	+39%	$14.12	Q4 2023
30 Sep 2023	0%	+0%	$312,152	30,306	+7,400	+32%	$10.30	Q3 2023
30 Jun 2023	0%	-0%	$377,491	22,906	-71,493	-76%	$16.48	Q2 2023
31 Mar 2023	0%	+0%	$864,695	94,399	+10,286	+12%	$9.16	Q1 2023
31 Dec 2022	0%	-0%	$602,249	84,113	-42,022	-33%	$7.16	Q4 2022
30 Sep 2022	0%	-0%	$632,000	126,135	-45,817	-27%	$5.01	Q3 2022
30 Jun 2022	0%	-0%	$420,000	171,952	-33,842	-16%	$2.44	Q2 2022
31 Mar 2022	0%	+0%	$1,406,000	205,794	+16,278	+8.6%	$6.83	Q1 2022
31 Dec 2021	0%	+0%	$1,531,000	189,516	+24,732	+15%	$8.08	Q4 2021
30 Sep 2021	0%	+0%	$1,615,000	164,784	+25,320	+18%	$9.80	Q3 2021
30 Jun 2021	0%	+0%	$939,000	139,464	+18,771	+16%	$6.73	Q2 2021
31 Mar 2021	0%	+0%	$1,091,000	120,693	+27,377	+29%	$9.04	Q1 2021
31 Dec 2020	0%	+0%	$624,000	93,316	+10,518	+13%	$6.69	Q4 2020
30 Sep 2020	0%	+0%	$417,000	82,798	+64,256	+347%	$5.04	Q3 2020
30 Jun 2020	0%	+0%	$150,000	18,542	+18,542	NEW	$8.09	Q2 2020
31 Dec 2019		-0%	$0	0	-89,192	-100%	$18.78	Q4 2019
30 Sep 2019	0%	0%	$371,000	89,192	0		$4.16	Q3 2019
30 Jun 2019	0%	0%	$258,000	89,192	0		$2.89	Q2 2019
31 Mar 2019	0%	0%	$128,000	89,192	0		$1.44	Q1 2019
31 Dec 2018	0%	0%	$230,000	89,192	0		$2.58	Q4 2018
30 Sep 2018	0%	-0%	$392,000	89,192	-43,470	-33%	$4.40	Q3 2018
30 Jun 2018	0%	-0%	$813,000	132,662	-3,448	-2.5%	$6.13	Q2 2018
31 Mar 2018	0%	+0%	$992,000	136,110	+15,573	+13%	$7.29	Q1 2018
31 Dec 2017	0%	+0%	$988,000	120,537	+88,494	+276%	$8.20	Q4 2017
30 Sep 2017	0%	0%	$336,000	32,043	+261	+0.82%	$10.49	Q3 2017
30 Jun 2017	0%	+0%	$351,000	31,782	+523	+1.7%	$11.04	Q2 2017
31 Mar 2017	0%	+0%	$302,000	31,259	+858	+2.8%	$9.66	Q1 2017
31 Dec 2016	0%	+0%	$316,000	30,401	+30,401	NEW	$10.39	Q4 2016

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.